Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer

Summary

Determine time-to-progression (TTP) for an escalating dose schedule for subjects with progressive metastatic renal cell carcinoma treated with sorafenib

Timeline

Start

2007-12

Primary completion

2009-07

Completion

2011-01

Drugs

Indications